chr17-59185130-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018304.4(PRR11):āc.205A>Gā(p.Ile69Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,461,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_018304.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRR11 | NM_018304.4 | c.205A>G | p.Ile69Val | missense_variant | 3/10 | ENST00000262293.9 | NP_060774.2 | |
PRR11 | XM_024450828.2 | c.205A>G | p.Ile69Val | missense_variant | 4/11 | XP_024306596.1 | ||
PRR11 | XM_047436387.1 | c.205A>G | p.Ile69Val | missense_variant | 4/11 | XP_047292343.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRR11 | ENST00000262293.9 | c.205A>G | p.Ile69Val | missense_variant | 3/10 | 1 | NM_018304.4 | ENSP00000262293.5 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251402Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135876
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461664Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727170
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2024 | The c.205A>G (p.I69V) alteration is located in exon 3 (coding exon 2) of the PRR11 gene. This alteration results from a A to G substitution at nucleotide position 205, causing the isoleucine (I) at amino acid position 69 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at